Skip to search formSkip to main contentSkip to account menu

HER2/Neu Status

Known as: ERBB2 Status, Her2/Neu Value 
The presence or absence of Her2/Neu on a tissue sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Biomarkers for personalized oncology: recent advances and future challenges.
  • M. Kalia
  • Metabolism: clinical and experimental
  • 2015
  • Corpus ID: 24795701
2011
2011
Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma.
2010
2010
Celecoxib and aromatase activity in breast cancer: Results from a prospective randomized preoperative trial.
1527 Background: COX-2 is overexpressed in many epithelial malignancies, including a subset of human breast cancers. Preclinical… 
2009
2009
Changing Therapy as a Consequence of the Behaviour of CETC during Adjuvant Trastuzumab Treatment in Patients with Her2/Neu Positive Breast Cancer.
Gene silencing, demethylation, translocations and amplifications crucially contribute to the growth potential and aggressiveness… 
2007
2007
[Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].
BACKGROUND AND OBJECTIVE To investigate the prognostic value of p53 and HER2/neu overexpression in epithelial ovarian cancer (EOC… 
2006
2006
Иммуноморфологическая характеристика процесса неоваскуляризации в метастазирующих аденокарциномах желудка с применением маркеров HER2/neu, Ki-67 и р53
Highly Cited
2002
Highly Cited
2002
Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
Review
1998
Review
1998
Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system
Little information is available on the molecular mechanisms underlying neuroendocrine tumorigenesis. To obtain an overview of the… 
Highly Cited
1993
Highly Cited
1993
Overexpression of HER2/neu oncogene in human pancreatic carcinoma.
Highly Cited
1988
Highly Cited
1988
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.
The HER2/neu protooncogene was found to be amplified in 6 of 109 primary adenocarcinoma tumors. No HER2/neu amplification was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License